641 related articles for article (PubMed ID: 21307646)
1. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.
Chong ZZ; Shang YC; Zhang L; Wang S; Maiese K
Oxid Med Cell Longev; 2010; 3(6):374-91. PubMed ID: 21307646
[TBL] [Abstract][Full Text] [Related]
2. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.
Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP
Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S
J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815
[TBL] [Abstract][Full Text] [Related]
4. Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth.
Acosta-Jaquez HA; Keller JA; Foster KG; Ekim B; Soliman GA; Feener EP; Ballif BA; Fingar DC
Mol Cell Biol; 2009 Aug; 29(15):4308-24. PubMed ID: 19487463
[TBL] [Abstract][Full Text] [Related]
5. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
6. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.
Wang L; Harris TE; Roth RA; Lawrence JC
J Biol Chem; 2007 Jul; 282(27):20036-44. PubMed ID: 17510057
[TBL] [Abstract][Full Text] [Related]
7. Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling.
Coffey RT; Shi Y; Long MJ; Marr MT; Hedstrom L
J Biol Chem; 2016 Mar; 291(10):5221-33. PubMed ID: 26740621
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids.
Dickinson JM; Fry CS; Drummond MJ; Gundermann DM; Walker DK; Glynn EL; Timmerman KL; Dhanani S; Volpi E; Rasmussen BB
J Nutr; 2011 May; 141(5):856-62. PubMed ID: 21430254
[TBL] [Abstract][Full Text] [Related]
9. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
10. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling.
Sciascia Q; Pacheco D; McCoard SA
J Dairy Sci; 2013 Apr; 96(4):2327-2338. PubMed ID: 23462168
[TBL] [Abstract][Full Text] [Related]
11. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance.
Ghosh J; Kobayashi M; Ramdas B; Chatterjee A; Ma P; Mali RS; Carlesso N; Liu Y; Plas DR; Chan RJ; Kapur R
J Clin Invest; 2016 Jul; 126(7):2621-5. PubMed ID: 27294524
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Rheb-mTOR signaling pathway in mammalian cells: constitutive active mutants of Rheb and mTOR.
Sato T; Umetsu A; Tamanoi F
Methods Enzymol; 2008; 438():307-20. PubMed ID: 18413257
[TBL] [Abstract][Full Text] [Related]
13. Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
Beevers CS; Chen L; Liu L; Luo Y; Webster NJ; Huang S
Cancer Res; 2009 Feb; 69(3):1000-8. PubMed ID: 19176385
[TBL] [Abstract][Full Text] [Related]
14. p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage.
Cam M; Bid HK; Xiao L; Zambetti GP; Houghton PJ; Cam H
J Biol Chem; 2014 Feb; 289(7):4083-94. PubMed ID: 24366874
[TBL] [Abstract][Full Text] [Related]
15. PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection.
Chong ZZ; Shang YC; Wang S; Maiese K
PLoS One; 2012; 7(9):e45456. PubMed ID: 23029019
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
[TBL] [Abstract][Full Text] [Related]
17. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion.
Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S
Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619
[TBL] [Abstract][Full Text] [Related]
18. Relieving autophagy and 4EBP1 from rapamycin resistance.
Nyfeler B; Bergman P; Triantafellow E; Wilson CJ; Zhu Y; Radetich B; Finan PM; Klionsky DJ; Murphy LO
Mol Cell Biol; 2011 Jul; 31(14):2867-76. PubMed ID: 21576371
[TBL] [Abstract][Full Text] [Related]
19. The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile.
Wang BT; Ducker GS; Barczak AJ; Barbeau R; Erle DJ; Shokat KM
Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15201-6. PubMed ID: 21876130
[TBL] [Abstract][Full Text] [Related]
20. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
